Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BCG vaccination to reduce respiratory infections and COVID-19-related hospitalization in older adults
NL-OMON49238Phase 4Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Apr 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronavirus disease 2019 (COVID-19) and Airways Infection comparing BCG vaccine with Placebo (2 arms). Primary endpoint: Clinically relevant respiratory tract infections. Started Apr 2020; status: active, not recruiting.
02
Drugs
bcg vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)Airways Infection
Beyond the preview
Go deeper on NL-OMON49238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON49238.